Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine infusion versus placebo for visual hallucinations in Parkinson's disease
NL-OMON45825Phase 2Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Apomorphine infusion with Placebo infusion (2 arms). Primary endpoint: Clinical Global Impression - Severity. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON45825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45825.